Oncotarget is a traditional journal that readers can access with no charge. It publishes online papers weekly; each weekly issue is printed on demand. The term “oncotarget” comprises of all molecules, cellular functions common in aging and cancer, cancer cells and microbes, atherosclerosis and neurodegeneration, neurons and lymphocytes. Under the leadership of many prominent scientists with vast experience, the journal helps researchers to improve the world of science. They are in business to ensure the world without diseases. Download output styles at Endnote.com
- Make scientific knowledge and results readily available to the public
- Maximize the impact of research by giving insightful reviews
- They enable scientific discoveries to be shared quickly
- They help get rid of the borders that separate different specialties and link the fields of biomedical science.
- To facilitate applications of clinical and basic science in the fight of diseases.
Members of the editorial board Andrew Schally a Nobel Prize winner and Carlo M. Croce (former Editor-in-Chief of Cancer Research) have published 10 and 27 papers for oncotarget respectively.
Since 2013, Bert Vogelstein, Alexander Varshavsky, Michael N. Hall and Stephen J. Elledge have won Breakthrough Prize, the highest price ever in the world of science.
Oncotarget is also the sponsor of Gordon Research Conference. They make sure they are maximizing their research by conducting a detailed team review. The journals popularity is because of their punctual insightful, great teamwork and effective efforts in helping their authors maximize the impact of each research.
What the journal does
The journal focuses on all the pathological basis of all cancer-related topics globally. From the best treatments methods that specialists apply to improve the condition of cancer patients to identifying the potential cancer patients. Oncotarget focuses on the impact of new therapeutic methods and management programs that can be administered to cancer patients and other things like patient’s quality life, satisfaction, and adherence. The journal also explores the connection between the old and new methods of cancer treatment to find a right balance between the two.
In conclusion, Oncotarget is dedicated to offering the best when it comes to cancer treatment. Visit their website for more information.